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Abstract
Background: Keloid is a type of scar which extends beyond the boundaries of the original wound. It can spread
to the surrounding skin by invasion. The use of Tualang honey is a possible approach for keloid treatment. The
objective of this study was to determine the antiproliferative effect of methanolic extraction of Tualang honey to
primary human keloid fibroblasts and to identify the volatile compounds in methanol extraction of Tualang honey.
Methods: Crude Tualang honey was extracted with methanol and then dried using rota vapor to remove
remaining methanol from honey. Normal and keloid fibroblasts were verified and treated with the extracted honey.
Cell proliferation was tested with [3-(4,5-dimethylthiazol-2-yi)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium, inner salt] (MTS) assay. Extraction of Tualang honey using methanol was carried out and the extracted
samples were analysed using gas chromatography-mass spectrometry (GC-MS). The result was analysed using SPSS
and tested with Kruskal-Wallis and Mann-Whitney tests.
Results: Methanolic extraction of honey has positive anti proliferative effect on keloid fibroblasts in a dose-
dependent manner. The presence of fatty acids such as palmitic acid, stearic acid, oleic acid, linoleic acid and
octadecanoic acid may contribute to the anti-proliferative effect in keloid fibroblasts.
Conclusions: The methanolic honey extraction has an antiproliferative effect on keloid fibroblasts and a range of
volatile compounds has been identified from Tualang honey. The antiproliferative effect of keloid fibroblasts
towards Tualang honey may involve cell signaling pathway. Identifying other volatile compounds from different
organic solvents should be carried out in future.
Background
Scar formation is the result of natural healing process
which occurs after wounds, trauma, burns, surgical inci-
sion or disease. In order to close a wound, skin repair
itself from normal to scar tissue and thus prevent infec-
tion [1]. Keloid is an end of the full spectrum of scar
which extends beyond the boundaries of the original
wound. It can spread to the surrounding skin by inva-
sion. Clinical appearance of keloid is a raised growth
and usually related with pruritus and pain. Keloid scars
commonly occur only in humans. Keloid healing
remains impaired since the pathogenesis of biochemical
mechanisms of keloid is still unknown [2]. Development
of keloid contains atypical fibroblasts and consists of
overabundant of extracellular matrix components
include collagen, fibronectin and certain proteoglycans.
Recently we reported the antimicrobial properties of
Tualang honey [3], but the volatile compounds in Tua-
lang honey from Malaysia and its effectiveness for treat-
ing keloid scar remain unknown. As Tualang honey is
found in Malaysia’s forest, various field of research on it
has been widely carried out by researchers. The honey
was used mainly to investigate its effect to certain dis-
eases and compared this traditional treatment to mod-
ern treatment. Recently, Tualang honey has been used
to determine its anticancer potential. For example, pre-
vious study has focused on the treatment of oral squa-
mous cell carcinomas (OSCC) and human osteosarcoma
(HOS) with various concentration of Tualang honey in
vitro. Current modern treatment to these types of oral
cancers such as surgery or radiotherapy can cause loss
of function, disfigurement and reduced quality of life.
From the finding, it is suggested that Tualang honey
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both oral cancer cell lines [4]. Human breast adenocar-
cinoma and cervical carcinoma (HeLa) cell lines were
found potential to be treated with Tualang honey as it
induced apoptosis of cancer cells via depolarization of
the mitochondrial membrane. Thus, Tualang honey is
found useful as an anticancer agent [5].
The Tualang tree which is also known as Koompassia
excelsa found widely in Southeast Asia rainforests best
known for the disk-shaped honeycombs which hang
from its horizontal branches. It is mostly found in low-
land forests of Peninsular Malaysia, southern Thailand,
northern Sumatra and Borneo, and can grow to heights
greater than 85 meters. The trees are valued by the
locals due to its honey. In fact, a standing Tualang tree
is more valuable for its honey than if it were felled for
its timber. The honey from the combs of this tree is
known as Tualang honey, and is produced by Apis dor-
sata or Asian rock bees [6].
Previously, continuous liquid-liquid extraction with
diethyl ether has been used for the extraction of polar
phenolic and acidic substances [7-9]. It has also been
used for the determination of linalool derivatives in
New Zealand honeys [10]. A simple liquid-liquid extrac-
tion method is advantageous as it does not involve heat-
ing which may lead to loss of volatiles or the formation
of artifacts [11]. Therefore, extraction of honey samples
using this method is more popular. The concentration
of volatile constituents in honey are very low, therefore
a sensitive technique such as gas chromatography-mass
spectrometry (GC-MS) is needed. GC-MS is a simple
instrument and requires very little time for quantifica-
tion of compounds when compared to other methods
such as high performance liquid chromatography. By
using GC-MS methods, many important organic com-
pounds have been detected in different types of honeys
[12-16].
To our knowledge, no report has focused on determi-
nation of the volatile profile of Tualang honey. A con-
tinuous liquid-liquid extraction technique using five
different organic solvents was selected due to its speed,
low cost, and lack of sample heating.
Methods
Skin Sample Collection
Two types of samples which were primary normal
human dermal fibroblasts (pNHDF) and primary keloid
human dermal fibroblasts (pKHDF) were obtained from
consented patients who underwent elective surgery at
Hospital Universiti Sains Malaysia (HUSM). Sample col-
lection was obtained after patients have agreed to give
their skin for research purposes, have read and signed
the informed consent forms. This study was approved
by Research Ethical Committee Universiti Sains Malay-
sia (Human).
Cell Culture
The skin samples were splitted into epidermal and der-
mal layers using dispase (2.4 units/mL DK-SFM)
(GIBCO™, Invitrogen, USA) and incubated overnight at
4°C. The epidermal layer was further processed to
obtain the keratinocytes and the dermal layer to obtain
fibroblasts cell. The primary human epidermal keratino-
cytes were maintained in an Epidermal Keratinocyte
Medium Defined (CELLNTEC, Switzerland) while the
primary human dermal fibroblasts were maintained in
Dulbecco’s Minimal Eagle Medium (D-MEM) (GIBCO
®,
Invitrogen™, USA).
Methanolic Extraction of Honey
Crude Tualang honey (50 g) was weighed and extracted
with selected organic solvent, methanol. Pure methanol
(100 mL) was poured to Tualang honey and the mixture
was mixed well using shaker. Anhydrous disodium sul-
fate powder (Na2SO4, BDH Laboratory supplies, Poole,
UK) was added (one third from the total honey/metha-
nol mixture) to remove residual water. The sample then
was saturated using filter paper which placed on filter
funnel to remove other residual from the extracted
honey. The extracts were then concentrated using rota-
vapor (R-200, BUCHI) to remove methanol from honey.
Concentrated honey was taken out from rota-vapor,
kept on sterile glass tube and further dried using
TECHNE Dri-Block to remove residual methanol. This
extraction procedure was carried out based on the
guidelines from National Poison Center, USM. The final
concentration is 0.5 g/mL.
Final concentration : 50 g − 100 mL
Xg− 1m L
Xg=5 0g / 1 0 0m L
=0 . 5g
Cell Treatment
Each primary normal human dermal fibroblast (pNHDF)
and primary keloid human dermal fibroblast (pKHDF)
cultures (100 μL) were seeded on separate 96-well plates
and incubated for 24 hrs in a humidified incubator con-
taining 5% CO2 incubator. After 70% confluence, cells
were treated with different concentrations of extracted
Tualang honey in each well. The concentrations were
12.5%, 6.25%, 3.13%, 1.56%,0 . 7 8 % ,0 . 3 9 % ,0 . 2 0 %a n d
0.10%. Positive control (Triton-X), negative control
(untreated cells), background control (plain supplemen-
ted medium) and substance control (honey dilution)
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48, and 72 hrs.
Cell Proliferation Assay
Cell proliferation assay, MTS [3-(4,5-dimethylthiazol-2-
yi)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium, inner salt] (Promega, USA) is a colorimetric
method for determining the number of viable cells in
proliferation assays. MTS is bioreduced by cells into a
formazan product that is soluble in tissue culture med-
ium. MTS and phenazine methosulfate (PMS) solution
were thawed. PMS solution (100 μL) was added to the 2
mL of MTS solution. The mixture was gently swirled to
ensure complete mixing of the combined MTS/PMS
solution. Combined MTS/PMS solution (20 μL) was
pipetted into each well of the 96-well plates. The plates
were incubated for 4 hrs at 37°C in a humidified 5%
CO2 atmosphere. After 4 hrs, absorbance of each well
was measured using ELISA reader with a test wave-
length at 490 nm and a reference wavelength at 630 nm.
The mean percentages of proliferated cells were calcu-
lated as below:
Percentage of proliferated cells by MTS = (ODsample/ODvalue) × 100 %
Where, ODsample = Optical Density of treatment samples
ODvalue = Optical Density of control
Analysis with GC-MS
Crude honey extract was added with 2 mL methanol
(MEOH). The sample was vortexed for 3 min and cen-
trifuged at 2500 rpm for 5 min. The clear top layer con-
taining the honey methanolic extraction was transferred
into a 1 mL autosampler vial before GC-MS injection.
The extract was analyzed with GC-MS.
GC-MS analyses were performed on a HP6890 GC
coupled with a HP5973 mass spectrometer. The column
was a HP-5MS fused-silica capillary column (30 m ×
0.25 mm i.d.; 0.25 μm film thickness), and helium run-
ning at a constant pressure of 14.5 psi was used as the
carrier gas. One microliter volumes were injected using
a splitless mode at an injector temperature of 250°C.
The oven temperature was ramped from 35 to 280°C (1
min hold) at a rate of 25°C/min. The oven temperature
was held at 310°C for 6 min following each analysis.
The total run time for each sample was approximately
90 min. The GC-MS interface temperature was set to
280°C. Mass spectrometry mode was used during analy-
tical scanning from 20-650 atomic mass unit (amu). The
ion source temperature was set to 250°C. The blank was
first injected, and was followed by the sample injection.
The chromatograms obtained from the total ion count
(TIC) were integrated without any correction for co-
eluting peaks and the results were expressed as total
abundance. All the peaks were identified based on mass
spectral matching (≥ 90%) from both the National Insti-
tute of Standards and Technology (NIST) and Wiley
libraries. Only compounds with 90% or greater spectral
matching accuracy are reported.
Statistical Analysis
The data from MTS assay was analyzed by SPSS (Statis-
tical Packages for Social Science) version 18.0 for win-
dows (Inc., Chicago, IL). The three independent
experiments were analyzed using Kruskal-Wallis test
while pairwise comparison was analyzed using Mann-
W h i t n e yt e s t .S i n c et h ed a t aw a sn o tn o r m a l l yd i s t r i b u -
ted, non-parametric test was used. It was considered to
be statistically significant if the p value < 0.05.
Results and Discussion
Proliferative Effect Determination of Tualang Honey
Methanolic Extraction on pNHDF and pKHDF
Figures 1 and 2 indicated that the number of normal
and keloid cell proliferation increases with the decrease
in the concentration of Tualang honey. The decrease in
proliferated cells was greater at higher concentration
when compared to lower concentrations. The prolifera-
tive effect of pKHDF was similarly observed following
24, 48 and 72 hrs of exposure. Using Kruskal-Wallis test
on ten concentrations of Tualang honey tested, only
three concentrations (0.39%, 0.78% and 6.25%) showed
significant difference, p < 0.05 following 24, 48 and 72
hrs of exposure to Tualang honey (Table 1) indicating
that there were no significant differences in proliferative
effect between the three time exposures.
Table 2 showed the proliferative effect of treated
pNHDF and pKHDF. From the result, it was found that
there was a significant difference (p < 0.05) in cell pro-
liferation of pNHDF and pKHDF at 0.10%, 1.56%, 6.25%
and 12.50% of honey concentrations where the prolifera-
tive effects were significantly higher in pNHDF when
compared to pKHDF. Meanwhile, the remaining con-
centrations showed no significant difference between
their inhibition values. Reduced cell proliferation was
found to be effective at 50%, 25%, 12.50% and 6.25% of
concentration.
The antiproliferative effect of methanolic extract of
honey at higher concentration suggests the possible
effective concentration of methanolic honey extracts to
treat pKHDF. Previous finding in which hepatocellular
carcinoma cells were treated with chloroform/methanol
extracts of honey found that the honey extracts exhib-
ited antiproliferative effect on HepG2 cells. However
with crude honey and petroleum ether honey extracts,
there was increased proliferation of HepG2 cells [17]. In
contrast, Ghashm et al. (2010) reported a different find-
ing where they found that unfractionated honey induced
cell-growth arrest of oral squamous cell carcinoma and
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G1 phase. These two different findings implicated that
different cells types affect the effectiveness of either
crude or extracted honey on cells.
Tualang honey acts on keloid fibroblasts by killing
some of the fibroblast cells. This action caused reduc-
tion of the number of viable cells thus decreased the
number of proliferated cells. Higher concentrations
(50% and 12.5%) of Tualang honey was cytotoxic to
fibroblasts cells but it became compatible to human
fibroblasts following dilution of the honey and safe to
treat human. Reduced rate of cell proliferation helps in
reduction of cell growth and thus retard the cell growth.
Cell growth retardation may minimize the size of keloid
scarring. In previous finding, honey was proven to be a
very effective agent for repressing the growth of bladder
cancer cell lines in vitro [18]. The positive effect of Tua-
lang honey to keloid fibroblasts suggest the role of Tua-
lang honey in minimizing scarring.
Determination of Compounds Detected from Honey
Methanolic Extract
Several compounds were detected and identified from
honey methanolic extractsu s i n gG C - M S .F r o mt h e
 
Figure 1 Proliferation of normal cells following 24, 48 and 72 hrs of incubation with various concentrations of methanolic extract of
Tualang honey.
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may induce the anti-proliferative effects on keloid fibro-
blasts such as furfural alcohol, 4-oxo-5-methoxy-2-pen-
ten-5-olide, 3-Hydroxy-2-methyl-4H-pyran-4-one, 2-
furoic acid, pyrocatechol, k e t o i s o p h o r o n e ,H M F ,e t h y l
palmitate, oleic acid, linoleic acid and octadecanoic acid,
2-hydroxy-1-[hydroxymethyl] ethyl ester (Table 3).
Honey has been used not only for food but also as a
traditional medicine. Recently, honey has gained public
attention due to its potential ability in treating diseases
and also in promoting health and well being [4]. Pre-
vious clinical studies have suggested that the positive
effect of honey or sucrose may involve in minimizing
keloids. Sucrose and mannose decreased in a dose-
Figure 2 Proliferation of keloid cells following 24, 48 and 72 hrs of incubation with various concentrations of methanolic extract of
Tualang honey.
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(III) collagen mRNA levels [19,20]. Furan and pyran
derivatives such as 2-acetylfuran, 5-methyl furfural, 3,5-
dihydroxy-6-methyl-2,3-dihydropyran-4-one, (5-methyl-
furan-2-yl) methanol and 5,5’-oxy-dimethylene-bis[2-fur-
aldehyde] which have been identified are the product of
Maillard reaction which acts as an indicator of the
absence of heat treatment and appropriate storage con-
dition [21] and is not involved in the antiproliferative
effect of honey.
Some types of honey depending on floral sources and
geographical regions, may contain phenolic compounds.
Phenolic compounds play a role as antioxidants, anti-
carcinogenic, anti-inflammatory, anti-microbial, anti-
atherogenic, anti-thrombotic and anti-proliferative
potential [4,17,18]. However, phenolic compounds were
not detected in methanolic extract of Tualang honey.
Different methods need to be used to determine the
phenolic content in honey for example using ethyl acet-
ate extract and analyzing with thin layer chromatogra-
phy (TLC) [22]. Thus, this could suggest that there are
possible compounds from methanolic extract of honey
that contribute to inhibition of cell proliferation. Tua-
lang honey that has been extracted using methanol con-
tains lipid including fatty acid esters such as oleic acid,
linoleic acid and octadecanoic acid, 2-hydroxy-1-[hydro-
xymethyl] ethyl ester. It was previously reported that
fatty acids show biological activity where they exhibit
cytotoxicity against HeLa cells and retarded tumor
growth [17]. This finding could support the presence of
fatty acids in methanolic extract of honey that contri-
bute to the inhibition of proliferative effect in keloid
fibroblasts.
Palmitic acid can be toxic to cells and cause cell death
in culture. Palmitic acid has been reported to inhibit
CNS insulin signaling in vitro [23]. Palmitic acid could
be one of the compounds involved in inhibiting keloid
fibroblasts cell proliferation which was confirmed to be
present in Tualang honey in our study.
This study is still at its elementary stage. The major
problems are due to time constraint and the difficulties
in maintaining primary cell culture. In future, collection
of blood sample from keloid patients can be done
instead of collection of keloid skin sample post surgery
s i n c eb l o o ds a m p l ei sm u c he a s i e rt oh a n d l ea n dl a r g e
scale of sample is possible. As Tualang honey is proven
to be non toxic and not harmful to be applied to the
human body, it should be further investigated in order
to determine what contributes to its unique properties
for example its fatty acids compounds. In our study,
since methanol extraction is found as the best solvent
for honey extraction, this extraction has been used to
Table 1 Cell proliferation in pKHDF after being treated with Tualang honey methanolic extracts at three different time
of exposure
Concentration of Tualang honey (%) Mean ± sd p value
24 h 48 h 72 h
0.10 92.68 ± 7.21 97.19 ± 2.13 98.45 ± 2.80 0.99
0.20 95.71 ± 11.20 95.27 ± 3.00 102.40 ± 2.77 0.44
0.39 91.67 ± 10.51 95.62 ± 2.60 98.39 ± 2.10 0.05*
0.78 83.35 ± 11.72 95.84 ± 4.51 97.98 ± 3.89 0.03*
1.56 77.52 ± 9.98 82.61 ± 10.62 87.91 ± 2.65 0.47
3.13 72.40 ± 9.94 69.03 ± 20.08 80.36 ± 2.39 0.60
6.25 3.89 ± 2.61 2.00 ± 3.10 6.62 ± 7.32 0.02*
12.50 2.88 ± 3.08 4.81 ± 3.67 3.28 ± 1.29 0.39
25.00 7.34 ± 4.96 5.93 ± 4.12 2.11 ± 3.16 0.06
50.00 6.36 ± 5.65 6.00 ± 5.55 3.65 ± 3.10 0.37
Cells calculated based on control value
Data presented as mean ± sd; sd: standard deviation. Kruskal-Wallis test *Significant (p value < 0.05)
Table 2 Cell proliferation in pNHDF and pKHDF after
being treated with Tualang honey between 0.10% to
50% concentration
Concentration of Tualang
honey (%)
Mean ± sd p value
pNHDF pKHDF
0.10 98.23 ± 3.78 90.15 ± 5.86 0.00*
0.20 98.75 ± 3.99 91.29 ± 13.58 0.53
0.39 96.19 ± 7.64 91.31 ± 12.86 0.51
0.78 96.97 ± 7.14 90.26 ± 14.95 0.48
1.56 94.98 ± 7.31 83.08 ± 10.31 0.00*
3.13 68.13 ± 34.04 76.17 ± 12.42 0.54
6.25 0.00 ± 3.83 3.51 ± 6.99 0.00*
12.50 0.24 ± 0.33 0.68 ± 0.66 0.00*
25.00 3.55 ± 4.18 2.36 ± 11.61 0.94
50.00 6.46 ± 5.79 2.95 ± 5.14 0.30
Cells calculated based on control value
Data presented as mean ± sd; sd: standard deviation.
aMann-Whitney test
*Significant (p value < 0.05)
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ethyl acetate can also be used as extracting solvent for
the treatment on fibroblasts and their effectiveness can
be compared with methanol extracts. This is helpful to
confirm our first claim and strengthen the underlying
results.
Conclusion
As methanol extract was found to be the best organic
solvent, methanolic extraction has been tested on fibro-
blasts cells for determining the ability of the honey
extract to inhibit cell proliferation. Our findings showed
the antiproliferative effect of methanolic honey extrac-
tion on keloid fibroblasts. Volatile compounds from
methanol extract of honey has been identified using
GC-MS and the presence of fatty acids from this extract
such as oleic acid, linoleic acid, octadecanoic acid, pal-
mitic acid and stearic acid may contribute to the anti-
proliferative effect in keloid fibroblasts. Further
investigations in determining antiproliferative effect of
keloid fibroblasts in relation to cell signaling pathway
and identifying other volatile compounds from different
organic solvents should be carried out. Investigations
from molecular mechanism are also needed to deter-
mine the proliferative mechanism in order to obtain bet-
ter findings. Even though honey is found to have the
ability to reduce scar, scar recurrence may occur. We
did not investigate if honey can prevent recurrence and
this needs further investigation. In conclusion, the effort
to treat keloid fibroblasts using traditional medicine
such as honey should be pursued as keloid responds
positively to Tualang honey treatment.
List of Abbreviations
amu atomic mass unit, CO2: Carbon dioxide; °C: degree celcius; °C/min:
degree celcius per minute; Na2SO4: Disodiumsulphate; ELISA: Enzyme-linked
Imunosorbent Assay; ≥: equal to or more than; FAMA: Federal Agriculture
Marketing Authority; GC-MS: Gas Chromatography-Mass Spectrometry; g
gram: hrs hours; HUSM: Hospital Universiti Sains Malaysia; MEOH: Methanol;
μL: microlitre; min: minute; mL: mililitre; MTS: 3-(4,5-dimethylthiazol-2-yi)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tertrazolium bromide, inner salt,
nm nanometer, % percent: PMS: phenazine methosulfate; pNHDF: primary
Table 3 Twenty seven compounds detected with methanolic extracted honey
Detected compounds Mean (Abundance) SD (Abundance) Coefficient of Variation (%)
furfural alcohol 1.15E + 08 44511402 38.59
Protoanemonine 2.75E + 07 725563.68 2.64
2-acetylfuran 2.27E + 07 5007827.8 22.10
2[5H]-furanone 2.40E + 07 1760998.5 7.34
2-hydroxycyclopent-2-en-1-one 1.18E + 08 12203793 10.37
4-oxo-5-methoxy-2-penten-5-olide 166949 86747.86 51.96
(5-methylfuran-2-yl)methanol 3948859 1153036.6 29.20
5-methyl furfural 2.27E + 07 2316696.8 10.21
2,4-dihydroxy-2,5-dimethyl-3[2H]-furan-3-one 2.59E + 07 7476341.8 28.88
Hyacinthin 1 1.58E + 07 619122.9 3.93
Hyacinthin 2 1.88E + 07 1412274 7.53
3-furoic acid methyl ester 2.49E + 07 381459.36 1.53
3-Hydroxy-2-methyl-4H-pyran-4-one 9458074 3279221.1 34.67
2-furoic acid 4.63E + 07 20121366 43.48
Ketoisophorone 1.90E + 07 24995107 131.75
3,5-dihydroxy-6-methyl-2,3-dihydropyran-4-one 3.07E + 08 31913403 10.39
5-acetoxymethyl-2-furaldehyde 2.27E + 07 964314.75 4.25
3,5-Dihydroxy-2-methyl-4H-pyran-4-one 2.93E + 07 6028182.9 20.56
Pyrocatechol 7686147 942361.21 12.26
HMF 1.75E + 09 439154881 25.04
palmitic acid 448760 38000.626 8.47
ethyl palmitate 126536 131167.6 103.66
5,5’-oxy-dimethylene-bis[2-furaldehyde] 2.87E + 07 3152723.3 10.98
linoleic acid 144296 9170.4678 6.36
oleic acid 105076 30963.499 29.47
Stearic acid 123760 15412.099 12.45
octadecanoic acid, 2-hydroxy-1-[hydroxymethyl] ethyl ester 43669 14338.711 32.83
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